One Year of COVID-19 mRNA Vaccines: Incredible Progress and Unfinished Business

Ravi Jhaveri

doi:10.1016/j.clinthera.2021.11.014

One Year of COVID-19 mRNA Vaccines: Incredible Progress and Unfinished Business

Ravi Jhaveri^*

^*Corresponding author for this work

Pediatrics

Research output: Contribution to journal › Editorial › peer-review

2 Scopus citations

Original language	English (US)
Pages (from-to)	2041-2043
Number of pages	3
Journal	Clinical Therapeutics
Volume	43
Issue number	12
DOIs	https://doi.org/10.1016/j.clinthera.2021.11.014
State	Published - Dec 2021

ASJC Scopus subject areas

Pharmacology (medical)
Pharmacology

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1016/j.clinthera.2021.11.014

Cite this

@article{094fcd17b5124961b5008a11026a9ba1,

title = "One Year of COVID-19 mRNA Vaccines: Incredible Progress and Unfinished Business",

author = "Ravi Jhaveri",

year = "2021",

month = dec,

doi = "10.1016/j.clinthera.2021.11.014",

language = "English (US)",

volume = "43",

pages = "2041--2043",

journal = "Clinical Therapeutics",

issn = "0149-2918",

publisher = "Excerpta Medica",

number = "12",

}

TY - JOUR

T1 - One Year of COVID-19 mRNA Vaccines

T2 - Incredible Progress and Unfinished Business

AU - Jhaveri, Ravi

PY - 2021/12

Y1 - 2021/12

UR - http://www.scopus.com/inward/record.url?scp=85121236074&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85121236074&partnerID=8YFLogxK

U2 - 10.1016/j.clinthera.2021.11.014

DO - 10.1016/j.clinthera.2021.11.014

M3 - Editorial

C2 - 34920853

AN - SCOPUS:85121236074

SN - 0149-2918

VL - 43

SP - 2041

EP - 2043

JO - Clinical Therapeutics

JF - Clinical Therapeutics

IS - 12

ER -

One Year of COVID-19 mRNA Vaccines: Incredible Progress and Unfinished Business

ASJC Scopus subject areas

UN SDGs

Access to Document

Other files and links

Cite this